Market Cap (In INR)
51.38 Billion
Revenue (In INR)
5.7 Billion
Net Income (In INR)
1.19 Billion
Avg. Volume
33.85 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 270.15-835.35
- PE
- 29.46
- EPS
- 21.67
- Beta Value
- 0.304
- ISIN
- INE07RO01027
- CUSIP
- -
- CIK
- -
- Shares
- 80482800.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Satish Waman Wagh
- Employee Count
- -
- Website
- https://www.supriyalifescience.com
- Ipo Date
- Details
- Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. It offers anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, antihypertensive, and anti-malarial products, as well as vitamins and xanthine derivatives. The company was founded in 1987 and is headquartered in Mumbai, India.
More Stocks
-
EBKDYErste Group Bank AG
EBKDY
-
ASHOKAAshoka Buildcon Limited
ASHOKA
-
KBSB
-
PCAR3
-
CREATIVEYECreative Eye Limited
CREATIVEYE
-
QLT
-
DPWIRESD.P. Wires Limited
DPWIRES
-
LCSHF